ArticleNature communications2024

Molecular and clinical analyses of PHF6 mutant myeloid neoplasia provide their pathogenesis and therapeutic targeting.

Yasuo Kubota et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.